Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production.
Bax HJ, Chauhan J, McCraw AJ, Grandits M, Stavraka C, Lentfer H, Hillyer T, Carroll S, Vigor K, Selkirk C, Figini M, Cheeseman J, Urbanowicz PA, Gardner RA, Spencer DIR, Westwood N, Mellor S, Spicer J, Josephs DH, Karagiannis SN.
Bax HJ, et al. Among authors: hillyer t.
MAbs. 2025 Dec;17(1):2451295. doi: 10.1080/19420862.2025.2451295. Epub 2025 Jan 20.
MAbs. 2025.
PMID: 39833133
Free article.